Cargando…

P066 A randomised, double-blind, placebo-controlled, single-dose, crossover, pilot study investigating the effects of cannabinol (CBN) 30 mg and 300 mg on sleep architecture and next-day function in insomnia disorder

INTRODUCTION: There is a clear need for novel interventions for insomnia disorder. Growing evidence suggests a role of the endogenous cannabinoid system in regulating circadian sleep-wake cycles, highlighting a potential avenue for novel therapeutics. Cannabinol (CBN), a trace cannabinoid formed thr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lavender, I, Suraev, A, McCartney, D, Irwin, C, Kevin, R, D'Rozario, A, Gordon, C, Marshall, N, Saini, B, McGregor, I, Grunstein, R, Yee, B, Hoyos, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Poster Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10109170/ http://dx.doi.org/10.1093/sleepadvances/zpac029.137

Ejemplares similares

Cannabinol (CBN; 30 and 300 mg) effects on sleep and next-day function in insomnia disorder (‘CUPID’ study): protocol for a randomised, double-blind, placebo-controlled, cross-over, three-arm, proof-of-concept trial
por: Lavender, Isobel, et al.
Publicado: (2023)

O006 Acute effects of combined cannabidiol (CBD) and ∆9-tetrahydrocannabinol (THC) in insomnia disorder: A randomised, placebo-controlled trial using high-density EEG
por: Suraev, A, et al.
Publicado: (2022)

Cannabinoid receptor 2 (Cb2r) mediates cannabinol (CBN) induced developmental defects in zebrafish
por: Amin, Md Ruhul, et al.
Publicado: (2022)

Orally administered cannabidiol does not produce false‐positive tests for Δ(9)‐tetrahydrocannabinol on the Securetec DrugWipe® 5S or Dräger DrugTest® 5000
por: McCartney, Danielle, et al.
Publicado: (2021)

Effects of cannabidiol on simulated driving and cognitive performance: A dose-ranging randomised controlled trial
por: McCartney, Danielle, et al.
Publicado: (2022)

Cannabidiol (CBD) and Δ(9)-tetrahydrocannabinol (THC) for chronic insomnia disorder (‘CANSLEEP’ trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial
por: Suraev, Anastasia, et al.
Publicado: (2020)

The “Next Day” Effects of Cannabis Use: A Systematic Review
por: McCartney, Danielle, et al.
Publicado: (2023)

The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence
por: Arnold, Jonathon C., et al.
Publicado: (2022)

Cannabidiol and Sports Performance: a Narrative Review of Relevant Evidence and Recommendations for Future Research
por: McCartney, Danielle, et al.
Publicado: (2020)

P018 The effects of zopiclone on sleep spindles in obstructive sleep apnea: A randomized placebo-controlled trial
por: Carter, S, et al.
Publicado: (2021)

Switching Ticagrelor to 600 mg or 300 mg Clopidogrel Loading Bridge in Patients with Unstable Angina
por: Cakal, Sinem, et al.
Publicado: (2021)

P050 Familiar locations and new locations: sleep’s role in the consolidation of spatial navigation information using a novel virtual Morris water maze task in older adults with mild cognitive impairment
por: Haroutonian, C, et al.
Publicado: (2021)

The effects of subacute exposure to a water-soluble cannabinol compound in male mice
por: Bailey, Melissa M., et al.
Publicado: (2022)

Cannabinol: History, Syntheses, and Biological Profile of the Greatest “Minor” Cannabinoid
por: Maioli, Chiara, et al.
Publicado: (2022)

Formulation development and optimization of Lamivudine 300 mg and Tenofovir Disoproxil Fumarate (TDF) 300 mg FDC tablets by D-optimal mixture design
por: Tibalinda, Prosper, et al.
Publicado: (2016)

Premedication with pregabalin 150mg versus 300mg for postoperative pain relief after laparoscopic cholecystectomy
por: Singh, Tanveer, et al.
Publicado: (2020)

P023 Quantitative EEG analysis of polysomnography in a case of Fatal Familial Insomnia
por: Churchward, T, et al.
Publicado: (2021)

P047 Slow Wave Dynamics in Mild Cognitive Impairment compared with Age Matched Controls: A High Density EEG study.
por: Chapman, J, et al.
Publicado: (2023)

O033 Predicting subjective sleep quality using multi-day actigraphy data: A machine learning approach
por: Kao, C, et al.
Publicado: (2021)

Insomnia subtypes characterised by objective sleep duration and NREM spectral power and the effect of acute sleep restriction: an exploratory analysis
por: Kao, Chien-Hui, et al.
Publicado: (2021)

The Efficacy of 100 and 300 mg Gabapentin in the Treatment of Carpal Tunnel Syndrome
por: Eftekharsadat, Bina, et al.
Publicado: (2015)

Transcriptome Highlights Cannabinol Modulation of Mitophagy in a Parkinson’s Disease In Vitro Model
por: Gugliandolo, Agnese, et al.
Publicado: (2023)

P114 The effect of light interventions on sleep macro- and micro-architecture in sleep and circadian rhythm disorders: A scoping review
por: Pun, T, et al.
Publicado: (2021)

O013 Preliminary Results from a Phase 1 Study of ALKS 2680, an Orexin-2 receptor Agonist, in Healthy Participants and Patients with Narcolepsy or Idiopathic Hypersomnia
por: Yee, B, et al.
Publicado: (2023)

Antitumor Effects of Delta (9)-Tetrahydrocannabinol and Cannabinol on Cholangiocarcinoma Cells and Xenograft Mouse Models
por: Leelawat, Surang, et al.
Publicado: (2022)

Efficacy of the Combination of Pinaverium Bromide 100 mg Plus Simethicone 300 mg in Abdominal Pain and Bloating in Irritable Bowel Syndrome: A Randomized, Placebo-controlled Trial
por: Schmulson, Max J., et al.
Publicado: (2020)

Neurological syndrome in an HIV-prevention trial participant randomized to daily tenofovir disoproxil fumarate (300 mg) and emtricitabine (200 mg) in Bondo, Kenya
por: Owino, Fredrick, et al.
Publicado: (2013)

Cost-Effectiveness Analysis of Canagliflozin 300 mg Versus Dapagliflozin 10 mg Added to Metformin in Patients with Type 2 Diabetes in the United States
por: Neslusan, Cheryl, et al.
Publicado: (2018)

P066 Abstract Withdrawn
Publicado: (2021)

Efficacy and safety of a single‐tablet regimen containing tenofovir disoproxil fumarate 300 mg, lamivudine 300 mg and efavirenz 400 mg as a switch strategy in virologically suppressed HIV‐1‐infected subjects on nonnucleoside reverse transcriptase inhibitor‐containing first‐line antiretroviral therapy in Pune, India
por: Dravid, A, et al.
Publicado: (2020)

Impaired Neurobehavioural Performance in Untreated Obstructive Sleep Apnea Patients Using a Novel Standardised Test Battery
por: D'Rozario, Angela L., et al.
Publicado: (2018)

Efficacy of Prolonged-Release Melatonin 2 mg (PRM 2 mg) Prescribed for Insomnia in Hospitalized Patients for COVID-19: A Retrospective Observational Study
por: Bologna, Carolina, et al.
Publicado: (2021)

Cost-Effectiveness of Once-Weekly Semaglutide 1 mg versus Canagliflozin 300 mg in Patients with Type 2 Diabetes Mellitus in a Canadian Setting
por: Stafford, Sara, et al.
Publicado: (2022)

Effectiveness and Tolerability of the Intensification of Canagliflozin Dose from 100 mg to 300 mg Daily in Patients with Type 2 Diabetes in Real Life: The INTENSIFY Study
por: Gorgojo-Martinez, Juan J., et al.
Publicado: (2023)

High-Pressure Synthesis of cBN Nanoparticles with High-Density Nanotwin Substructures
por: Ying, Pan, et al.
Publicado: (2019)

Peridynamic Simulation to Fracture Mechanism of CBN Grain in the Honing Wheel Dressing Process
por: Wang, Fuwei, et al.
Publicado: (2021)

Anti-Inflammatory Effects of Minor Cannabinoids CBC, THCV, and CBN in Human Macrophages
por: Gojani, Esmaeel Ghasemi, et al.
Publicado: (2023)

P143 Sleep-dependent declarative memory consolidation and NREM sleep EEG oscillations in older adults with obstructive sleep apnea
por: Teh, J, et al.
Publicado: (2021)

Myasthenia gravis: MuSK MG, late-onset MG and ocular MG
por: Deymeer, Feza
Publicado: (2020)

Adverse drug events observed with 150 mg versus 300 mg secukinumab for the treatment of moderate to severe plaque psoriasis: A systematic review and meta-analysis
por: Zhang, Li, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e802qcmigmvir1bpqchd9sd56k